Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
Clinical Scorecard: Temple Lung Center | Enrolling Clinical Trials
At a Glance
Category Detail
Condition Lung Diseases Key Mechanisms Advancements in basic, translational, and clinical research for effective therapies. Target Population Patients with serious and debilitating lung diseases. Care Setting Clinical trials at Temple Lung Center.
Key Highlights
Comprehensive lung disease clinical trials program. Pioneering effective therapies for various lung conditions. Focus on asthma, COPD, interstitial lung disease, and lung cancer. Guideline-Based Recommendations
Diagnosis
Utilize clinical trials to assess new diagnostic tools and biomarkers. Management
Incorporate innovative treatments from ongoing clinical trials. Monitoring & Follow-up
Regular follow-up in clinical trials to evaluate treatment efficacy and safety. Risks
Consider potential risks associated with novel therapies in clinical trials. Patient & Prescribing Data
Adults with uncontrolled asthma, COPD, interstitial lung disease, and lung cancer.
Participation in clinical trials may provide access to cutting-edge therapies.
Clinical Best Practices
Engage patients in discussions about clinical trial options. Monitor patient outcomes closely during trial participation. Educate patients on the potential benefits and risks of trial involvement. References
